Purpose The aim of this study was to investigate (i) the influence of drug solid-state (crystalline or dissolved in the polymer matrix) on the melt viscosity and (ii) the influence of the drug concentration, temperature and shear rate on polymer crystallization using rheological tests. Methods Poly (ethylene oxide) (PEO) (100.000 g/mol) and physical mixtures (PM) containing 10-20-30-40% (w/w) ketoprofen or 10% (w/w) theophylline in PEO were rheologically characterized. Rheological tests were performed (frequency and temperature sweeps in oscillatory shear as well as shear-induced crystallization experiments) to obtain a thorough understanding of the flow behaviour and crystallization of PEO-drug dispersions. Results Theophylline did not dissolve in PEO as the complex viscosity (η*) of the drug-polymer mixture increased as compared to that of neat PEO. In contrast, ketoprofen dissolved in PEO and acted as a plasticizer, decreasing η*. Acting as a nucleating agent, theophylline induced the crystallization of PEO upon cooling from the melt. On the other hand, ketoprofen inhibited crystallization upon cooling. Moreover, higher concentrations of ketoprofen in the drug-polymer mixture increasingly inhibited polymer crystallization. However, shear-induced crystallization was observed for all tested mixtures containing ketoprofen. Conclusion The obtained rheological results are relevant for understanding and predicting HME processability (e.g., barrel temperature selection) and downstream processing such as injection moulding (e.g., mold temperature selection). 
INTRODUCTION
In the pharmaceutical industry, hot-melt extrusion (HME) is a continuous and highly flexible manufacturing technology used for the production of solid dispersions (SDs) (1) . HME is carried out using a heated barrel containing one or two rotating screws performing four basic steps in a continuous manner: solid conveying, melting, mixing and shaping of the raw materials (i.e., polymer + API) into a product of uniform shape and density. Processing of amorphous or semi-crystalline polymers via HME is performed above their respective glass transition temperature (T g ) or melting temperature (T m ). A practical rule of thumb is often applied to process the materials, the barrel temperature is generally set 10-20°C above the T g or T m of the polymer (2) . It should be noted that the set barrel temperature is different from the actual product temperature due to the transfer of mechanical energy from the screws into the molten drug-polymer mixture and that the product temperature cannot be accurately measured (3) . However, this rule of thumb is not always useful: for example, T g of Soluplus is 72°C but the processing temperature recommended by the manufacturer is between 120 and 180°C (depending on the screw configuration) in order to decrease the melt viscosity to within the processable range (i.e., 10,000-1000 Pa.s).
The processability of the drug formulation via pharmaceutical HME is also determined by the rheological properties of the drug-polymer mixture. The rheological properties of polymer melts and composites have long been studied in the plastics industry to allow efficient and optimal production of high quality products (4, 5) . When polymers are deformed, they exhibit complex rheological behaviour, which is of major importance for their processing and the resulting end product properties. Most polymers used in the pharmaceutical and plastics industry are thermoplastics. This kind of polymers can be processed because they soften during processing at elevated temperatures. In all processing steps of HME (i.e., solid conveying, melting, mixing, shaping) the rheological properties of the polymer melt are important in the selection of the processing conditions (e.g., barrel temperature, mould temperature). Most polymers also exhibit a shear thinning behaviour; i.e. the viscosity decreases at higher shear rates. This observation is due to the disentanglement of polymer chains during shearing at higher rates. This determination is also relevant from a processing point of view since also the screw speed and screw configuration can influence the flow behaviour.
Furthermore, it is well known that the drug substance can plasticize the polymer melt by increasing the free volume between the polymer chains, hence improving the processability. In practice, this can be easily noticed by a reduction of the torque during extrusion. Also the drug concentration and the physical/chemical drug-polymer interactions are important parameters controlling the processability of the drug formulation. Aho (6) published an overview of the use of rheology for pharmaceutical hot melt extrusion. Not only are rheological data useful for selecting the processing conditions, they are also valuable for solving problems often encountered in extrusion such as die swell and shark skinning which often related to the viscoelastic properties.
In production processes as injection moulding and fiber spinning, high pressures and shear rates are encountered which influence the crystallization kinetics and morphology upon cooling of semi-crystalline polymers (7, 8) . Flowinduced crystallization has been studied in the plastics industry to simulate the injection moulding process (9) . However, to our best knowledge, flow-induced crystallization has not been studied on pharmaceutical solid dispersion formulations containing semi-crystalline polymers. Also the effect of the drug concentration and drug solid-state upon polymer crystallization during cooling remains unclear. Many fillers in polymer composites (e.g., talc, silica) are known to act as nucleating agents, enabling faster crystallization kinetics (10) . In a similar way, drugs could act as nucleating agents or on the other hand inhibit the polymer crystallization. Jeong et al. showed that differences in polymer crystalline microstructure affect the drug release of papaverine from polycaprolactone microstructures (11) . Therefore, it is essential to understand all parameters influencing the final properties of the solid dispersion system (i.e., solid-state, polymer crystallization).
In this study, a thorough rheological characterization of solid dispersions containing a water soluble semi-crystalline polymer is performed. The rheological characterization is performed to obtain information about: (i) the solubility of the two model drugs (ketoprofen and theophylline) in the polymer matrix, (ii) the viscosity in function of shear rate and temperature and (iii) to understand the influence of shear, temperature, drug solid-state and drug content upon polymer crystallization.
EXPERIMENTAL Materials
Poly (ethylene oxide) (PEO, POLYOX™ WSR N-10 NF, Mw: 100.000 g/mol, Dow Company) is a water soluble polymer with a glass transition temperature of −67°C and a melting temperature of 65°C. Two model drugs were selected based on their different melting points. Ketoprofen (S.I.M.S., Firenze, Italy) is a nonsteroidal anti-inflammatory drug (NSAID) with a low melting point of 94°C. Theophylline (Theophylline anhydrous powder, BASF, Ludwigshafen, Germany) is a drug used in therapy for respiratory diseases with a high melting temperature (i.e., 273°C). Physical drugpolymer mixtures were made with a mortar and pestle containing 10 -20 -30 -40% (w/w) ketoprofen and 10% (w/w) theophylline in PEO.
Methods

A HAAKE MARS
® III rheometer (Thermo Scientific, Massachusetts, USA) equipped with a parallel plate geometry (d = 20 mm) and a Peltier temperature module (TM-PE-P) was used for all experiments, except for the time sweep experiment where the RheoScope module was used. Zero gap determination and loading of the samples were done at the test temperature. Samples were first softened at the heated bottom plate and equilibrated at the measuring gap (h = 1 mm) for 15 min to erase all thermal history prior to the measurement. Dynamic oscillatory experiments (i.e., frequency sweeps and temperature sweeps) were performed within the linear viscoelastic region (LVR) at a strain deformation of 2% using the CD-AS mode. Viscoelastic properties were measured using a frequency sweep performed at 70, 80 and 100°C from 490 to 0.1 rad/s. The data measured during a frequency sweep is the storage (G') and loss (G^) modulus as a function of frequency, and captures information about the material's elastic and viscous behaviour at different time intervals. At their cross over point (G'=G^), the viscous and elastic properties of the material are equal. The frequency at the cross over point is also related to the characteristic mean relaxation time of the material since time is the reciprocal of frequency. Furthermore, a time sweep (20 min) was performed on the 40% ketoprofen mixture at the lowest test temperature (70°C) using the RheoScope module (Thermo Scientific, Massachusetts, USA). This module allowed simultaneous determination of the rheological parameters (e.g., complex viscosity) and visual examination via microscopy using a 20× magnification lens. This time sweep experiment was performed to verify if all ketoprofen crystals were dissolved in the molten PEO matrix.
Also, temperature sweeps were performed, monitoring η*, G' and G^as a function of temperature, on all samples using a constant frequency of 6.28 rad/s. Samples were first molten and equilibrated at 100°C followed by a cooling run from 100°C at 2°C/min until crystallization of the polymer was completed. After solidification, a subsequent heating run at 2°C/min until 100°C was performed. The drug-polymer mixtures were later extruded using a co-rotating vertical twin screw extruder (PME 5, Xplore instruments, Netherlands) to verify their processability based on the complex viscosity (i.e., 10,000 Pa.s) measured during the temperature sweep heating run. The mini extruder was used in recirculation mode by using a recirculation channel to prolong the residence time of the raw materials in the extruder (12) . The physical mixture was manually fed (6 g ) and extruded at a set barrel temperature which corresponds to the upper viscosity limit (i.e., 10,000 Pa.s), determined from the temperature s w e e p h e a t i n g r u n : K e t o 1 0 % = 5 0°C ; K e t o 20% = 55°C; Keto 30% = 60°C; Keto 40% = 63°C; PEO = 66°C; Theo 10% = 70°C. The residence time (± 2 min) of the drug-polymer mixture in the extruder was controlled using the extruder recirculation channel until a constant extruder motor current (i.e., indicating a homogenous mixture) was measured before discharging the extrudate. The screw speed was kept constant at 50 rpm and all data (i.e., barrel temperature and extruder motor current) was logged via the Micro Compounder software (v10.1).
The temperature at the crossover point determined from the temperature sweep cooling run (T G'=G^) was defined as the nominal crystallization temperature and is further used during flow-induced crystallization experiments (FIC). FIC experiments were performed on the PEO mixtures with 0, 10, 20, 30 and 40% (w/w) ketoprofen using the following protocol (see Fig. 1 for the schematic presentation of the protocol):
1) The sample was equilibrated for 15 min at 100°C followed by a cooling ramp (5°C/min) to the isothermal crystallization temperature (T c ) (upper plot, Fig. 1 ). During the cooling ramp, the measuring gap was kept constant (1 mm) using the thermo gap option in the Rheowin software (version 4.61). The isothermal crystallization temperature (T c ) is set at T G'=G" + ΔT. T c was determined for all samples to evaluate the influence of shear at an equal temperature difference (ΔT = 10°C) above the nominal crystallization temperature (i.e., T G'=G" ). ΔT was determined during preliminary tests such that no crystallization was observed during the subsequent shear step. 2) If shear was part of the experiment, a rotational shear step with a shear rate of 0.5, 1 or 2 s -1 was applied for 192, 100 and 52 s (i.e., ts = shearing time) respectively starting at T c for a total strain (γ) of 94. Since the HAAKE MARS® III rheometer is a stress controlled rheometer, the shearing time (i.e., ts) was determined to obtain approximately the same total strain (i.e., the area under the curve of the lower plot as showed in Fig. 1 . Lower plot: the shearing step applied for a total time of ts (shearing time) starting from time zero (i.e., when T c is reached). The area under the curve of the lower plot between time zero and ts is the total strain.
3) A dynamic time sweep (f = 6.28 rad/s, γ = 2%) was performed after the shear step to monitor the evolution of η* as function of time until PEO was crystallized.
Furthermore, quiescent isothermal crystallization experiments were performed on the samples containing ketoprofen and theophylline using various T c 's. These experiments are similar to the FIC experiments but without step two (i.e., the shear step). The various T c 's used during these experiments are listed in Table I . The evolution of relative polymer crystallinity of the samples was analysed in the same way as for the FIC experiments which is described in the following paragraphs.
Following the FIC experiments, the crystallization kinetics of the samples was analysed using the commonly applied Avrami equation (Eq. 1) as described in (10) to understand the influence of the drug concentration, the isothermal crystallization temperature and the shear rate on the polymer crystallization kinetics.
Were n being the Avrami exponent and k is the crystallization rate constant, which is dependent on nucleation and crystal growth. Since the units of k are dependent on n, also K can be defined as k = K n . X(t) is the evolution of relative crystallinity as function of time calculated from the rheological data via the method proposed by Khanna (13) (Eq. 2):
Herein, η * min and η * max are the respective minimum and maximum values determined at the plateau values of the Sshaped curves over the experimental time range. The η * max was determined arbitrarily (due to the torque limit of the rheometer). It should be stressed that this determination of relative crystallinity is not exact but the time scales are the same, allowing to determine the impact of the shear rate and the various T c 's on the polymer crystallization kinetics (7). Furthermore, determination of n and k involved calculation of the respective slope and intercept from the linearized Avrami equation (Eq. 3).
In order to perform the Avrami fit correctly, the induction time was subtracted from the absolute time when performing the Avrami fit as described in (14) . The induction time is the time between the absolute zero time (i.e., when T c is reached) and the initial start of crystallization.
RESULTS & DISCUSSION Drug Solubility and Viscoelastic Properties
The solubility of a drug substance in the polymer matrix can be measured by a rheological method suggested by Suwardie and Yang (15, 16) . This method relies on the plasticizing ability of a dissolved drug substance which disrupts the polymer structure, hence decreasing the viscosity of the drug-polymer system. On the other hand, crystalline material in the polymer matrix will act as a filler and increase the viscosity of the drugpolymer mixture. Previous studies have shown that the drug concentration and the particle shape are both important factors influencing the viscosity of drug-polymer suspensions (17, 18) . In this study, the miscibility/solubility of ketoprofen (T m = 94°C) and theophylline (T m = 273°C) in PEO was investigated at various temperatures (70, 80 and 100°C). In order to obtain the zero shear rate viscosity (η 0 ), the complex viscosity η* as function of angular frequency (ω) was fitted with the Ellis model between 0.1 and 490 rad/s (Eq. 4, with n < 1).
where k is associated with the relaxation time and n with the power law index. Table II lists the calculated zero shear rate viscosities obtained from the frequency sweep data. ), the shear rate had a strong influence on the viscosity of these materials (19, 20) . As can be seen from Fig. 2(a-d) , the sample containing 10% theophylline in PEO showed a higher complex viscosity at all test temperatures compared to neat PEO. Therefore, the viscosity ratio at the highest temperature (100°C) is higher than 1 as illustrated in Fig. 2d . On the other hand, Fig. 2d shows a lower viscosity ratio as function of ketoprofen concentration, even at temperatures below the melting point of ketoprofen (i.e., 70 and 80°C). This indicated that ketoprofen is dissolving in the polymer matrix. Schachter et al. (21) have shown using solid-state NMR that the carboxylic group of ketoprofen and the ether oxygen of PEO form hydrogen bonds even below the melting temperatures of both crystalline drug and polymer. These interactions are strongly facilitating the dissolution of ketoprofen molecules in the PEO melt.
Furthermore, the 40% ketoprofen mixture was further analysed using the Rheoscope module to verify whether all ketoprofen crystals were dissolved at the lowest test temperature (70°C). A time sweep over 20 min (Fig. 3) showed that the complex viscosity was decreasing, indicating dissolution of ketoprofen in the polymer matrix. While ketoprofen crystals could still be observed in the PEO phase 4 min into the experiment (Fig. 3 inset left) , these particles were completely dissolved after 10 min (inset right).
Besides solubility information, dynamic frequency sweeps are commonly used to provide information about the viscoelastic properties of polymer melts. Herein, the crossover point (G' = G^) provided information on the solid-or viscous-like behaviour of the materials at various temperatures. The crossover frequencies (rad/s), listed in Table III , show that the crossover point of all materials increased at higher test temperature. The resulting faster relaxation time is due to the higher molecular mobility of the material at elevated temperatures. These data also showed that a higher ketoprofen content increased the molecular mobility of the mixture (i.e., shorter relaxation times). The viscosity ratio also reduced at higher temperatures, indicating that the plasticizing ability of ketoprofen is higher at elevated temperature. On the other hand, theophylline does not change the viscoelastic properties with increasing temperature to the same extend as ketoprofen. Figure 4a shows the rheological data during the cooling phase as this provided information about the crystallization of PEO upon cooling from the melt. Crystallization of PEO is clearly influenced by the drug solid-state in the melt. At a temperature of 100°C, ketoprofen was completely molten and hence plasticized the PEO matrix. Upon cooling from the melt, the material behaved more like a liquid since the loss modules (G^) is higher than the storage modulus (G') (see Fig. 4b ). However, upon cooling, G^increased at a slower rate than G'. Eventually PEO crystallized and behaved more like a solid when G' > G". The temperature at the crossover point was arbitrarily defined as the crystallization temperature (T G' = G " ). Ketoprofen tended to inhibit the crystallization of PEO since the T G'=G^d ecreased linearly as a function of ketoprofen concentration as shown in Fig. 4c . This phenomenon can be explained by the hindering of local arrangements of PEO chains within a crystal lattice. On the other hand, theophylline increased the crystallization temperature (T G'=G^= 50°C), indicating that theophylline acted as a nucleating agent. Nucleating agents are often inducing the formation of more and smaller crystal structures. This phenomenon has been described for many composite materials in the plastics industry (7, 22) .
Temperature Sweep
Furthermore, Fig. 4d shows the heating experiment subsequent to the cooling experiment. Again, higher ketoprofen concentrations reduced the complex viscosity of the solid dispersions upon heating from the solidified material compared to the pure polymer, indicating the plasticizing effect of ketoprofen upon the molten material. Another interesting observation is that the viscosity drop during melting of the polymer is sharper for the drugpolymer mixtures compared to the neat polymer, suggesting that a more uniform distribution of polymer crystals was formed during the cooling run for the drug-polymer mixtures. Gupta et al. (23, 24) described that the melt viscosity processing range for pharmaceutical hot-melt extrusion should be between 10,000 and 1000 Pa.s. The horizontal line in Fig. 3d highlights this upper viscosity limit (10,000 Pa.s). It should be stressed that the temperature sweep is measured at a frequency of 6.28 rad/s, which is low from a processing point of view. However, using this method, the minimal required processing temperature can be determined for pharmaceutical HME. To confirm the latter method, extrusion experiments were performed using temperatures close to the upper viscosity limit (10,000 Pa.s). Smooth extrudates were produced at the set barrel temperatures (Fig. 5) .
Flow-Induced and Isothermal Crystallization Figure 6 shows the plots of the relative crystallinity as function of absolute time from the moment the experiment reached the isothermal crystallization temperature. These plots clearly show that the applied shear flow induced the crystallization of PEO. This phenomenon is well described in literature (7, 25, 26) . By applying a flow in an undercooled melt (i.e., T g < T test < T m ), nuclei are induced and the crystal growth rate is enhanced. Furthermore, the Avrami parameters were calculated and are listed in Table IV . To elucidate the influence of the applied shear rate and the drug loading on the crystallization kinetics, the dimensionless half crystallization time (Θ t1/2 = t 1/2shear /t 1/2quiescent ) and the dimensionless rate constant (Θ K = K shear /K quiescent ) are plotted in function of the various applied shear rates (Fig. 7a-b) . From  Fig. 7a , it can be seen that the samples containing less ketoprofen (i.e., 10-20%) showed a similar decrease in the half crystallization time (Θ t1/2 < 1) compared to neat PEO in function of the applied shear rate. On the other hand, samples containing 30-40% ketoprofen in PEO showed a different crystallization behaviour. The half crystallization time is longer using a shear rate of 1 s −1 compared to 0.5 s −1 (see Fig. 6 ). This can be due to the faster relaxation times of the material containing high ketoprofen concentrations (as observed during the frequency sweep experiments). Fowler et al. (27) has shown that plasticizers can decrease the crystallization growth rate. Vleeshouwers et al. (8) reported that not only the applied shear rate but also the shearing time (t s ) can affect the crystallization rate. For all samples, the highest shear rate (2 s −1 ) increased the crystallization speed due to the stable nuclei that are formed when shearing at higher rate. In Fig. 7b , the dimensionless rate constant increases more as a function of the applied shear rate for pure PEO and the lower drug concentrations (10 and 20%) than for the higher ketoprofen concentrations (30 and 40%). This indicates that the pure polymer and the lower drug concentrations are more susceptible to shear flow to enhance polymer crystallization compared to the 30 and 40% ketoprofen mixture. From these results, it can be concluded that in order to induce stable nuclei, not only the applied shear rate, but also a sufficient shearing time is needed when the material is highly plasticized. Figure 8 shows the curves of the relative crystallinity as a function of time for the isothermal crystallization experiments. It is evident that the temperature has a strong impact on the crystallization speed. For example, the half crystallization time for the 10% (w/w) ketoprofen mixture was reduced by 11 min when lowering Tc from 49 to 48°C. Also the ketoprofen concentration has a profound influence on the crystallization speed, e.g. the half crystallization time at 48°C for the 10% ketoprofen mixture was 8.24 min vs. 51 min for the 20% ketoprofen mixture tested at 47°C. From a processing point of view, a highly plasticized mixture will need much lower mould temperatures to solidify after injection into the mould. On the other hand, as the sample containing theophylline was 50% crystallized after 5.46 min at 53°C, the presence of crystalline theophylline particles accelerated the crystallization of PEO compared to neat PEO (t 1/2 = 23 min at 54°C). 
